129 related articles for article (PubMed ID: 9517278)
21. Predictors of mortality in verapamil overdose: usefulness of serum verapamil concentrations.
Mégarbane B; Karyo S; Abidi K; Delhotal-Landes B; Aout M; Sauder P; Baud FJ
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):385-9. PubMed ID: 21205222
[TBL] [Abstract][Full Text] [Related]
22. Surprisingly delayed escalation of severe verapamil poisoning.
Tuka V; Ricarova B; Janota T; Malik J; Kotrlikova E
Eur J Emerg Med; 2009 Apr; 16(2):100-2. PubMed ID: 19194302
[TBL] [Abstract][Full Text] [Related]
23. [Diabetic nephropathy with nephrotic syndrome--apropos of 2 cases. Advantages of combined conversion enzyme inhibitor and non-dihydropyridine calcium antagonist treatment].
Guelpa G
Praxis (Bern 1994); 2000 Aug; 89(34):1331-8. PubMed ID: 11021187
[TBL] [Abstract][Full Text] [Related]
24. [The toxicity of slow-release verapamil and chronic kidney disease].
Huelmos A; Alegría E; Vázquez C
Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
[No Abstract] [Full Text] [Related]
25. Individualizing treatment with verapamil for cluster headache patients.
Blau JN; Engel HO
Headache; 2004; 44(10):1013-8. PubMed ID: 15546265
[TBL] [Abstract][Full Text] [Related]
26. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
27. Hepatic injury possibly induced by verapamil.
Nash DT; Feer TD
JAMA; 1983 Jan; 249(3):395-6. PubMed ID: 6848831
[No Abstract] [Full Text] [Related]
28. Verapamil for hypertension.
Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
[No Abstract] [Full Text] [Related]
29. Modified release verapamil induced cardiogenic shock.
Nanda U; Ashish A; Why HJ
Emerg Med J; 2005 Nov; 22(11):832-3. PubMed ID: 16244356
[TBL] [Abstract][Full Text] [Related]
30. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
31. [Negative inotropic effects and constipation caused by verapamil?].
Joost HG; Müller A
Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S5. PubMed ID: 10818993
[No Abstract] [Full Text] [Related]
32. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
[No Abstract] [Full Text] [Related]
33. High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure.
Gokel Y; Paydas S; Duru M
Am J Emerg Med; 2000 Oct; 18(6):738-9. PubMed ID: 11043636
[No Abstract] [Full Text] [Related]
34. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Al-Waili NS; Hasan NA
Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
[TBL] [Abstract][Full Text] [Related]
36. Adverse interaction between clonidine and verapamil.
Jaffe R; Livshits T; Bursztyn M
Ann Pharmacother; 1994; 28(7-8):881-3. PubMed ID: 7949506
[TBL] [Abstract][Full Text] [Related]
37. Acute calcium channel blocker withdrawal-induced cardiac arrest.
Peeters LEJ; den Uil CA; Feyz L; van den Bemt PMLA; Daemen J; Versmissen J
Neth J Med; 2019 Dec; 77(9):341-343. PubMed ID: 31814590
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
Nakayama J; Koga T; Furue M
Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
40. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
